system
lupu
erythematosu
sle
autoimmun
diseas
affect
virtual
organ
bodi
common
africanamerican
hispan
women
childbear
age
untreat
sle
pregnanc
relat
advers
outcom
addit
uncontrol
sle
pregnanc
associ
exacerb
requir
immunosuppress
therapi
due
hormon
chang
involv
estradiol
progesteron
prolactin
lead
proinflammatori
state
also
higher
morbid
mortal
sle
patient
lower
socioeconom
statu
nonwhit
patient
higher
incid
sle
wors
outcom
lower
surviv
rate
previou
epidemiolog
studi
shown
african
american
especi
suscept
ethnic
eg
hispan
recogn
higher
risk
unit
state
diffus
alveolar
hemorrhag
dah
lifethr
complic
sle
present
hypoxemia
dyspnea
cough
bloodting
expector
mortal
high
common
histopatholog
diagnosi
pulmonari
capillar
dah
manifest
lupu
seen
case
case
report
dah
pregnanc
report
case
young
primigravida
femal
week
gestat
present
cough
rash
sore
throat
fever
chill
dyspnea
ct
thorax
suggest
multifoc
pneumonia
bronchoscopi
confirm
dah
also
found
acut
pancreat
retinopathi
associ
sle
hospit
sleassoci
acut
pancreat
retinopathi
seen
respect
retinopathi
lead
seriou
visual
deficit
patient
activ
diseas
pubm
search
use
key
word
dah
sle
acut
pancreat
retinopathi
pregnanc
date
perform
previous
healthi
primigravida
week
gestat
past
medic
histori
asthma
depress
anxieti
present
outsid
hospit
osh
initi
present
urgent
care
clinic
suspect
streptococc
pharyng
report
sick
contact
discharg
oral
amoxicillin
mg
time
daili
day
complet
improv
two
week
go
urgent
care
clinic
present
emerg
depart
ed
fever
sore
throat
discharg
home
stabl
condit
one
week
later
broke
rash
hand
feet
mouth
present
osh
ed
worsen
symptom
fever
bodi
ach
dri
cough
rash
medic
prenat
vitamin
supplement
initi
vital
sign
osh
ed
temperatur
blood
pressur
mmhg
puls
beat
per
minut
respiratori
rate
breath
per
minut
oxygen
satur
room
air
physic
exam
remark
erythemat
slightli
indur
plaqu
overli
subtl
scale
glabella
malar
cheek
nasal
bridg
templ
spare
nasolabi
fold
upper
chest
finger
palm
scatter
vesicl
contain
hemorrhag
fluid
also
found
multipl
ulcer
hard
palat
heart
lung
abdomin
musculoskelet
exam
unremark
lab
notabl
lactat
white
blood
cell
count
wbc
kul
hemoglobin
hb
gdl
platelet
kul
patient
peripher
blood
smear
reveal
occasion
spherocyt
chest
xray
cxr
admiss
unremark
given
intraven
fluid
iv
antibiot
suspect
sepsi
initi
infecti
workup
includ
neg
serial
blood
cultur
day
neg
group
streptococci
throat
cultur
neg
nasopharyng
mrsa
cultur
patient
met
system
inflammatori
respons
syndrom
criteria
remain
tachycard
heart
rate
beat
per
minut
tachypn
rr
breath
per
minut
max
day
admiss
transfer
facil
escal
care
bronchoscopi
rule
atyp
infect
patient
remain
febril
tachycard
borderlin
hypotens
systol
blood
pressur
mmhg
day
start
highflow
nasal
cannula
hypoxia
antibiot
regimen
includ
intraven
iv
azithromycin
mg
daili
day
total
iv
cefepim
g
everi
h
day
iv
vancomycin
everi
h
day
increas
mg
everi
h
day
also
treat
oral
acyclovir
mg
time
daili
day
switch
iv
acyclovir
mgkg
mg
everi
h
day
persist
fever
tachycardia
tachypnea
day
becam
acut
dyspneic
hypox
oxygen
satur
room
air
day
admiss
repeat
cxr
suggest
bilater
pleural
effus
differenti
diagnosi
multifoc
pneumonia
pulmonari
edema
figur
patient
suspect
complic
pneumonia
treat
antibiot
see
iv
fluid
despit
manag
intens
care
unit
icu
symptom
persist
ct
chest
contrast
figur
show
bilater
airspac
diseas
due
multifoc
pneumonia
versu
infectiousinflammatori
etiolog
antibiot
continu
extens
infecti
workup
neg
infecti
workup
includ
neg
toxoplasmosi
gondii
pcr
borrelia
burgdorferi
iggigm
antibodi
acidfast
bacilli
cultur
neg
hiv
antigenantibodi
combo
fourthgener
neg
respiratori
statu
deterior
requir
emerg
endotrach
intub
mechan
ventil
day
admiss
hemoglobin
decreas
gdl
gdl
day
admiss
worsen
leukopenia
kdl
thrombocytopenia
kdl
lymphopenia
peripher
smear
neg
sign
hemolysi
patient
immunolog
workup
summar
tabl
patient
posit
coomb
test
lactat
dehydrogenas
ldh
rang
iul
elev
haptoglobin
normal
antinuclear
antibodi
ana
posit
speckl
pattern
antirnp
antismith
complement
complement
neg
autoimmun
serolog
includ
antidoublestrand
dna
antissaro
antissbla
antiphospholipid
antibodi
skin
biopsi
taken
patient
lesion
show
interfac
dermat
vacuolar
atroph
epidermi
consist
cutan
lupu
also
subtl
foci
vascular
damag
rais
possibl
superimpos
leukocytoclast
vascul
bronchoalveolar
lavag
bal
confirm
suspicion
alveolar
hemorrhag
bal
respiratori
cultur
gram
stain
grew
colonyform
unit
per
ml
candida
albican
also
seen
fungal
cultur
respiratori
viral
bacteri
panel
neg
includ
adenoviru
pcr
coronaviru
pcr
metapneumoviru
pcr
rhinovirusenteroviru
pcr
influenza
pcr
influenza
b
pcr
parainfluenza
viru
pcr
rsv
pcr
chlamydophila
pneumonia
pcr
mycoplasma
pneumonia
pcr
serum
herp
simplex
type
detect
parvoviru
igm
neg
igg
elev
index
tuberculosi
quantiferon
gold
neg
tracheal
aspir
acidfast
bacilli
neg
time
estim
proteinuria
h
urin
sediment
show
dysmorph
cell
red
blood
cell
cast
therefor
due
low
suspicion
lupu
nephriti
patient
kidney
biopsi
treatment
initi
iv
methylprednisolon
g
day
plasmapheresi
treatment
continu
iv
methylprednisolon
mgkg
due
patient
grave
clinic
statu
multispecialti
collabor
perform
share
decisionmak
rheumatolog
matern
fetal
medicin
transfus
medicin
critic
care
specialist
due
patient
intub
discuss
patient
mother
keep
pregnanc
viabl
initi
treatment
cyclophosphamid
consent
risk
benefit
review
prior
treatment
first
dose
cyclophosphamid
patient
develop
high
fever
hypotens
tachycardia
highdos
methylprednisolon
blood
cultur
show
candidemia
treat
intraven
iv
fluconazol
ophthalmolog
evalu
neg
viriti
suggest
bilater
cotton
wool
spot
favor
retinopathi
secondari
sle
patient
extub
receiv
cyclophosphamid
iv
mg
initi
dose
month
later
receiv
mg
day
discharg
day
admiss
cours
complic
acut
abdomin
pain
lipas
amylas
alkalin
phosphatas
iul
total
protein
gdl
total
bilirubin
mddl
albumin
gdl
ct
chest
abdomen
pelvi
without
iv
contrast
perform
rule
mesenter
ischemia
periton
confirm
suspicion
acut
pancreat
patient
treat
cyclophosphamid
prior
develop
acut
pancreat
rheumatolog
gener
surgeri
believ
caus
acut
pancreat
due
high
diseas
activ
sle
versu
cyclophosphamid
howev
druginduc
pancreat
cyclophosphamid
consid
patient
discharg
hydroxychloroquin
mg
twice
daili
prednison
taper
initi
dose
mg
daili
week
mg
daili
month
mg
daili
week
mg
week
prior
deliveri
note
creactiv
protein
level
assess
hospit
due
initi
presum
infect
level
assess
followup
mgdl
neg
week
gestat
patient
found
preterm
prematur
ruptur
membran
led
spontan
labor
given
magnesium
sulfat
neuroprotect
also
continu
outpati
oral
prednison
mg
daili
patient
success
deliv
healthi
babi
week
gestat
vagin
deliveri
sle
autoimmun
disord
primarili
affect
women
childbear
age
sever
complic
sle
includ
lupu
nephriti
dah
acut
pancreat
rare
manifest
sle
caus
rule
prior
make
associ
sle
pregnanc
like
caus
flare
untreat
primigravida
woman
dah
rare
rapidli
fatal
associ
sle
estim
mortal
rate
howev
recent
case
seri
report
surviv
rate
dah
consist
hospit
admiss
associ
sle
usual
present
patient
previou
histori
sle
also
present
initi
manifest
lupu
although
rare
common
associ
dah
lupu
nephriti
seen
case
differenti
diagnosi
dah
broad
rheumatolog
infecti
coagulopath
pharmacolog
rheumatolog
caus
includ
sle
goodpastur
syndrom
antiphospholipid
syndrom
vascul
pregnant
women
present
hemoptysi
caus
need
exclud
prior
make
diagnosi
dah
includ
trauma
infect
tuberculosi
bacteri
viral
fungal
malign
bronchogen
carcinoma
choriocarcinoma
carcinoid
vascular
pulmonari
hypertens
arterioven
malform
pulmonari
embol
connect
tissu
diseas
sle
granulomatosi
polyangi
goodpastur
syndrom
cardiac
cardiomyopathi
mitral
valv
stenosi
congenit
heart
diseas
pharmacolog
cocain
anticoagul
antiplatelet
pseudohemoptysi
gastrointestin
bleed
epistaxi
dah
sepsismimick
howev
pregnant
patient
sle
suscept
pneumonia
due
immun
dysregul
form
sle
immunosuppress
therapi
patient
hemoptysi
diagnosi
dah
difficult
case
dah
present
hypoxemia
dyspnea
cough
bloodting
hemoptysi
seen
case
patient
also
fever
chest
pain
dah
confus
pneumonia
pulmonari
edema
seen
patient
initi
treat
antibiot
osh
due
lack
clinic
improv
transfer
tertiari
care
facil
cxr
typic
show
bilater
opacif
peripher
involv
ct
thorax
typic
show
groundglass
opacif
bal
show
increas
number
hemorrhag
aliquot
hemosiderin
macrophag
stain
prussian
blue
biopsi
show
diffus
alveolar
damag
pulmonari
capillar
bland
pulmonari
hemorrhag
higher
risk
complic
untreat
newli
diagnos
patient
sle
pregnanc
howev
clear
pariti
higher
risk
complic
data
controversi
complic
includ
preterm
labor
preeclampsia
emerg
csection
deep
vein
thrombosi
dvt
infect
intrauterin
growth
restrict
intrauterin
fetal
death
spontan
miscarriag
also
higher
risk
matern
death
patient
found
preterm
labor
like
relat
sle
multidisciplinari
approach
manag
women
childbear
age
sle
preconcept
risk
assess
pregnanc
manag
matern
fetal
medicin
rheumatolog
recommend
sle
control
least
month
prior
concept
manag
sle
pregnanc
difficult
especi
previou
diagnosi
seen
patient
patient
strong
famili
histori
sle
mother
grandmoth
suffer
initi
manifest
sle
first
pregnanc
stress
import
screen
patient
prior
pregnanc
univers
guidelin
manag
dah
includ
pregnant
patient
due
lack
report
case
clinic
trial
treatment
base
expert
opinion
result
case
seri
data
studi
involv
dah
associ
type
vascul
high
clinic
consider
earli
initi
diagnosi
aggress
treatment
puls
methylprednisolon
combin
cyclophosphamid
mainstay
treatment
dah
import
discuss
patient
teratogen
effect
cyclophosphamid
drug
cross
placenta
also
associ
prematur
ovarian
failur
risk
ovarian
failur
depend
cumul
effect
drug
dose
age
patient
older
women
higher
risk
due
less
ovarian
reserv
fetal
effect
cyclophosphamid
utero
exposur
remain
unknown
cyclophosphamid
current
pregnanc
categori
x
studi
fetal
effect
cyclophosphamid
mice
publish
show
increas
testicular
cancer
compar
control
group
addit
decreas
spermatogenesi
ovarian
follicl
number
observ
intervent
group
rituximab
also
use
success
sever
case
report
consid
standard
care
support
treatment
mechan
ventil
blood
transfus
consid
necessari
plasmapheresi
help
remov
antigenantibodi
complex
blood
may
use
refractori
case
whether
plasmapheresi
improv
surviv
unknown
case
report
dah
pregnanc
tabl
summar
case
year
case
publish
age
gestat
treatment
modal
outcom
pregnanc
report
case
dah
complic
sle
pregnanc
decis
made
termin
pregnanc
administ
cyclophosphamid
one
patient
receiv
azathioprin
initi
recurr
dah
iv
cyclophosphamid
use
patient
surviv
patient
age
rang
year
old
gestat
age
rang
week
week
patient
diagnos
sle
year
year
year
month
case
prior
present
dah
two
case
diagnos
sle
antepartum
period
first
case
involv
week
gestat
requir
emerg
csection
due
fetal
bradycardia
found
dah
hemoptysi
seen
endotrach
tube
csection
radiolog
find
bal
confirm
dah
subsequ
diagnos
sle
posit
immunolog
find
lupu
nephriti
antiphospholipid
syndrom
lymphocytopenia
thrombocytopenia
second
case
patient
week
gestat
diagnos
dah
initi
diagnos
sle
week
gestat
suspect
dah
week
gestat
present
dyspnea
hemoptysi
noncontrast
ct
thorax
show
diffus
groundglass
opac
nodular
consolid
treat
puls
methylprednisolon
improv
deliv
healthi
babi
week
gestat
csection
bal
confirm
dah
treat
cyclophosphamid
puls
steroid
respiratori
statu
deterior
despit
treatment
treat
extracorpor
membran
oxygen
plasmapheresi
total
time
success
extub
improv
respiratori
statu
pregnanc
termin
case
case
rais
question
whether
immedi
deliveri
viabl
pregnanc
done
dah
diagnos
current
guidelin
deliveri
babi
pregnant
patient
dah
addit
prognosi
dah
deliveri
unknown
case
high
diseas
activ
sle
refractori
treatment
deliveri
consid
studi
need
determin
treatment
guidelin
time
deliveri
pregnant
patient
sle
dah
current
recommend
includ
multidisciplinari
approach
multipl
specialti
expert
opinion
conjunct
thorough
discuss
patient
weigh
risk
eg
fetal
growth
restrict
sle
aggrav
benefit
matern
fetal
outcom
furthermor
patient
found
acut
pancreat
like
associ
sle
acut
pancreat
rare
sle
seen
case
import
rule
pharmacolog
obstruct
toxic
caus
acut
pancreat
attribut
sle
etiolog
pancreat
lupu
due
medic
use
treat
lupu
like
azathioprin
cyclosporin
rare
cyclophosphamid
cyclophosphamid
given
prior
patient
develop
acut
pancreat
consid
etiolog
howev
patient
high
diseas
burden
sle
believ
primari
caus
acut
pancreat
report
case
dah
acut
pancreat
young
nonpregn
femal
treat
success
rituximab
cyclophosphamid
present
catastroph
case
lupusinduc
vascul
multipl
organ
dysfunct
syndrom
manifest
retinopathi
dah
acut
pancreat
preval
less
patient
unusu
serolog
result
detect
plasma
antidsdna
antibodi
high
titer
antismith
antibodi
univers
accept
antidsdna
antibodi
correl
diseas
activ
sle
patient
especi
lupu
nephriti
howev
recent
studi
demonstr
antidsdna
correl
clinic
serolog
criteria
effect
diseas
activ
patient
unclear
manifest
develop
initi
present
sle
complic
develop
result
delay
diagnosi
treatment
sle
dah
lifethreaten
diseas
high
mortal
rate
earli
recognit
prompt
treatment
import
surviv
undiagnos
untreat
pregnant
patient
sle
like
complic
pregnanc
especi
diagnosi
delay
close
monitor
crucial
case
demonstr
catastroph
present
sle
pregnant
patient
sever
multipl
organ
dysfunct
syndrom
involv
pulmonari
hematolog
dermatolog
ocular
gastrointestin
system
case
patient
lack
respons
antibiot
sepsi
strong
famili
histori
sle
diagnost
workup
prompt
team
pursu
altern
diagnosi
sle
patient
respiratori
failur
decreas
hemoglobin
chest
xray
worsen
opac
heighten
suspicion
dah
case
highlight
import
use
multispecialti
approach
manag
rapidli
fatal
condit
use
collabor
approach
treatment
steroid
plasmapheresi
cyclophosphamid
led
surviv
mother
fetu
guidelin
need
manag
pregnant
patient
sle
dah
time
deliveri
